Elafibranor emerged as a potential chemotherapeutic drug for non-muscle invasive bladder cancer

Elafibranor emerged as a potential chemotherapeutic drug for non-muscle invasive bladder cancer

Intravesical infusion of chemotherapeutics is highly recommended by several clinical guidelines for treating nonmuscle invasive bladder cancer (NMIBC). However, cytotoxic chemotherapeutics can cause a series of side effects, which greatly limits their application. Herein, a starvation therapy strate...

Full description

Bibliographic Details
Main Authors: Wang Wang, Danni Shan, Guanyi Wang, Xiongmin Mao, Wenjie You, Xiaolong Wang, Zijian Wang
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Cell Insight
Subjects:
Elafibranor
Bladder cancer
Conditional reprogramming cell
Drug development
Preclinical study
Online Access:http://www.sciencedirect.com/science/article/pii/S277289272400004X

Internet

http://www.sciencedirect.com/science/article/pii/S277289272400004X

Similar Items